Clinical Advisory Board

 

Santosh Kesari, M.D., Ph.D., FANA

Dr. Santosh Kesari is a Professor of Neurosciences at UC San Diego School of Medicine, and Director of Neuro-oncology at Moores UCSD Cancer Center. His research investigates the biology of gliomas with the aim of developing new therapeutics for patients with brain tumors. He has a long-standing interest in neural development and cancer stem cells and is focusing on their role in the formation of brain tumors and resistance to treatments.

Mai H. Le, M.D.

Mai is a strategic advisor for biotechnology companies with a focus in oncology and immunotherapy. Dr. Le has over 8 years of oncology drug development experience that includes small molecules, biologics, medical devices and companion diagnostics strategy. She previously served as a medical director at Calithera Biosciences, Plexxikon Inc., Onyx Pharmaceuticals and Proteolix, Inc (acquired by Onyx Pharmaceuticals), and most recently, as the Chief Medical Officer at OncoSec Medical, Inc. Dr. Le obtained a medical degree from the University of Rochester School of Medicine and Dentistry and trained in Laboratory Medicine at University of California, San Francisco.

Boris Minev, MD, Ph.D.

Boris is currently the Director of Immunotherapy and Translational Oncology at Genelux Corporation studying the phenotype and characterization of metastasized cancer cells circulation. Dr. Minev previously worked as the Principal Investigate at the Laboratory of Tumor Immunology and Immunotherapy at the Moores UCSD Cancer Center. Dr. Minev has an extensive experience with cancer vaccines, having worked closely on the development of the first tumor vaccine to be approved by a regulatory body (Melacine).